Envoy Medical, Inc. (COCH)
NASDAQ (CM) NASDAQ (CM) Primary 
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
Envoy Medical, Inc. (COCH) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.32 per share a year ago.
Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Envoy Medical, Inc. (COCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Envoy Medical, Inc. (COCH) Upgraded to Buy: Here's Why
Envoy Medical, Inc. (COCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates
Envoy Medical, Inc. (COCH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.37 per share a year ago.
Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?
Envoy Medical, Inc. (COCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates
Envoy Medical, Inc. (COCH) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.27 per share a year ago.
Envoy Medical Is Pursuing Filling A Hearing Industry Void
Envoy Medical is a hearing device company that offers fully implantable devices for people with moderate to severe hearing loss. The company's second device, Acclaim, has been granted Breakthrough Device status and is about to begin clinical trials for FDA approval. Envoy's devices offer advantages such as no external device, no cleaning required, no risk of costly replacement, and 24/7 usage.
